A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Last updated: May 9, 2025
Sponsor: University of Chicago
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pulmonary Fibrosis

Arthritis And Arthritic Pain

Lung Injury

Treatment

N/A

Clinical Study ID

NCT00470327
14163A
1R21AI126031-01
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Interstitial lung disease

Exclusion

Exclusion Criteria:

  • Does not have Interstitial lung disease

Study Design

Total Participants: 4000
Study Start date:
September 01, 2005
Estimated Completion Date:
December 31, 2030

Connect with a study center

  • University of Chicago

    Chicago, Illinois 60637
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.